Fernando Ezquer
Fernando Ezquer
Sub-Director Centro de Medicina Regenerativa, Facultad de Medicina Clínica Alemana Universidad del Desarrollo
Dirección de correo verificada de udd.cl
Título
Citado por
Citado por
Año
Systemic administration of multipotent mesenchymal stromal cells reverts hyperglycemia and prevents nephropathy in type 1 diabetic mice
FE Ezquer, ME Ezquer, DB Parrau, D Carpio, AJ Yañez, PA Conget
Biology of Blood and Marrow Transplantation 14 (6), 631-640, 2008
3522008
The antidiabetic effect of mesenchymal stem cells is unrelated to their transdifferentiation potential but to their capability to restore Th1/Th2 balance and to modify the …
F Ezquer, M Ezquer, D Contador, M Ricca, V Simon, P Conget
Stem cells 30 (8), 1664-1674, 2012
1322012
Endovenous administration of bone marrow-derived multipotent mesenchymal stromal cells prevents renal failure in diabetic mice
F Ezquer, M Ezquer, V Simon, F Pardo, A Yañez, D Carpio, P Conget
Biology of Blood and Marrow Transplantation 15 (11), 1354-1365, 2009
1072009
Differential distribution of low‐density lipoprotein‐receptor‐related protein (LRP) and megalin in polarized epithelial cells is determined by their cytoplasmic domains
MP Marzolo, MI Yuseff, C Retamal, M Donoso, F Ezquer, P Farfán, Y Li, ...
Traffic 4 (4), 273-288, 2003
1022003
Intravitreal administration of multipotent mesenchymal stromal cells triggers a cytoprotective microenvironment in the retina of diabetic mice
M Ezquer, CA Urzua, S Montecino, K Leal, P Conget, F Ezquer
Stem cell research & therapy 7 (1), 1-17, 2016
712016
Non alcoholic steatohepatitis a precursor for hepatocellular carcinoma development
CM Jiang, CW Pu, YH Hou, Z Chen, M Alanazy, L Hebbard
World journal of gastroenterology: WJG 20 (44), 16464, 2014
66*2014
Intravenous administration of multipotent stromal cells prevents the onset of non-alcoholic steatohepatitis in obese mice with metabolic syndrome
M Ezquer, F Ezquer, M Ricca, C Allers, P Conget
Journal of hepatology 55 (5), 1112-1120, 2011
662011
Preconditioning of adipose tissue-derived mesenchymal stem cells with deferoxamine increases the production of pro-angiogenic, neuroprotective and anti-inflammatory factors …
C Oses, B Olivares, M Ezquer, C Acosta, P Bosch, M Donoso, P Leniz, ...
PLoS One 12 (5), e0178011, 2017
552017
High fat diet-induced skeletal muscle wasting is decreased by mesenchymal stem cells administration: implications on oxidative stress, ubiquitin proteasome pathway activation …
J Abrigo, JC Rivera, J Aravena, D Cabrera, F Simon, F Ezquer, M Ezquer, ...
Oxidative medicine and cellular longevity 2016, 2016
492016
Featured Article: Dexamethasone and rosiglitazone are sufficient and necessary for producing functional adipocytes from mesenchymal stem cells
D Contador, F Ezquer, M Espinosa, M Arango-Rodriguez, C Puebla, ...
Experimental Biology and Medicine 240 (9), 1235-1246, 2015
492015
MSC transplantation: a promising therapeutic strategy to manage the onset and progression of diabetic nephropathy
ME Ezquer, FE Ezquer, ML Arango-Rodríguez, PA Conget
Biological Research 45 (3), 289-296, 2012
432012
Two complementary strategies to improve cell engraftment in mesenchymal stem cell-based therapy: Increasing transplanted cell resistance and increasing tissue receptivity
FE Ezquer, ME Ezquer, JM Vicencio, SD Calligaris
Cell adhesion & migration 11 (1), 110-119, 2017
422017
Proregenerative microenvironment triggered by donor mesenchymal stem cells preserves renal function and structure in mice with severe diabetes mellitus
F Ezquer, M Giraud-Billoud, D Carpio, F Cabezas, P Conget, M Ezquer
BioMed research international 2015, 2015
412015
Stem cell exosomes inhibit angiogenesis and tumor growth of oral squamous cell carcinoma
L Rosenberger, M Ezquer, F Lillo-Vera, PL Pedraza, MI Ortúzar, ...
Scientific reports 9 (1), 1-12, 2019
342019
The antidiabetic effect of MSCs is not impaired by insulin prophylaxis and is not improved by a second dose of cells
F Ezquer, M Ezquer, V Simon, P Conget
PLoS One 6 (1), e16566, 2011
322011
Mesenchymal stem cell therapy in type 1 diabetes mellitus and its main complications: from experimental findings to clinical practice
M Ezquer, M Arango Rodriguez, MG Giraud Billoud, F Ezquer
OMICS International, 2014
302014
Could cancer and infection be adverse effects of mesenchymal stromal cell therapy?
ML Arango-Rodriguez, F Ezquer, M Ezquer, P Conget
World journal of stem cells 7 (2), 408, 2015
272015
Intravenous administration of anti-inflammatory mesenchymal stem cell spheroids reduces chronic alcohol intake and abolishes binge-drinking
F Ezquer, P Morales, ME Quintanilla, D Santapau, C Lespay-Rebolledo, ...
Scientific reports 8 (1), 1-15, 2018
262018
Could donor multipotent mesenchymal stromal cells prevent or delay the onset of diabetic retinopathy?
F Ezquer, M Ezquer, M Arango‐Rodriguez, P Conget
Acta ophthalmologica 92 (2), e86-e95, 2014
252014
Administration of multipotent mesenchymal stromal cells restores liver regeneration and improves liver function in obese mice with hepatic steatosis after partial hepatectomy
F Ezquer, J Bahamonde, YL Huang, M Ezquer
Stem cell research & therapy 8 (1), 1-18, 2017
232017
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20